CCSG support for planning and evaluation activities is requested in this competing renewal for meetings of the Consortium's External Advisory Board, senior leadership retreats, and visits from strategic advisors. During the prior grant period, CCSG funds supported highly valuable activities of this kind, including: 1) Five meetings of the Consortium's External Advisory Board that resulted in recommendations that have been influential in the Consortium's recent strategic planning, with most having been implemented or currently undergoing implementation;2) inter-institutional planning retreats with senior leaders and faculty to plan and assess the Consortium's strategic direction, progress, and emerging and developing research programs such as viral pathogenesis and stem/progenitor cell biology;and 3) visits of strategic advisors to provide insight on such topics as the development and application of imaging in research and biomarker discovery and planning a phase I clinical trials program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-39
Application #
8561895
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-01-01
Budget End
2013-12-31
Support Year
39
Fiscal Year
2013
Total Cost
$60,788
Indirect Cost
$23,188
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Gantt, Soren; Orem, Jackson; Krantz, Elizabeth M et al. (2016) Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants. J Infect Dis 214:36-44
Cheng, Guang-Shing; Campbell, Angela P; Xie, Hu et al. (2016) Correlation and Agreement of Handheld Spirometry with Laboratory Spirometry in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 22:925-31
Rufener, Gregory A; Press, Oliver W; Olsen, Philip et al. (2016) Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab. Cancer Immunol Res 4:509-19
Yu, Jeffrey; Storer, Barry E; Kushekhar, Kushi et al. (2016) Biomarker Panel for Chronic Graft-Versus-Host Disease. J Clin Oncol 34:2583-90
Cohen, Stacey A; Laurino, Mercy; Bowen, Deborah J et al. (2016) Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice. Cancer 122:393-401
Mather, Cheryl A; Mooney, Sean D; Salipante, Stephen J et al. (2016) CADD score has limited clinical validity for the identification of pathogenic variants in noncoding regions in a hereditary cancer panel. Genet Med 18:1269-1275
Chen, Robert; Gopal, Ajay K; Smith, Scott E et al. (2016) Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma. Blood 128:1562-6
Martin, Paul J; Fan, Wenhong; Storer, Barry E et al. (2016) Replication of associations between genetic polymorphisms and chronic graft-versus-host disease. Blood 128:2450-2456
Song, Xiaoling; Schenk, Jeannette M; Diep, Pho et al. (2016) Measurement of Circulating Phospholipid Fatty Acids: Association between Relative Weight Percentage and Absolute Concentrations. J Am Coll Nutr 35:647-656
Santiago-Torres, Margarita; Kratz, Mario; Lampe, Johanna W et al. (2016) Metabolic responses to a traditional Mexican diet compared with a commonly consumed US diet in women of Mexican descent: a randomized crossover feeding trial. Am J Clin Nutr 103:366-74

Showing the most recent 10 out of 1027 publications